Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Upstream Bio (UPB) EBITDA Margin (2023 - 2025)

Upstream Bio (UPB) has 2 years of EBITDA Margin data on record, last reported at 5911.57% in Q3 2025.

  • For Q3 2025, EBITDA Margin fell 244007.0% year-over-year to 5911.57%; the TTM value through Sep 2025 reached 5566.77%, changed N/A, while the annual FY2024 figure was 3558.82%, 187336.0% down from the prior year.
  • EBITDA Margin reached 5911.57% in Q3 2025 per UPB's latest filing, down from 5800.11% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 2345.78% in Q1 2024 and bottomed at 5911.57% in Q3 2025.